Fremont, CA, United States of America

Licen Xu


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Licen Xu: Innovator in Cancer Treatment

Introduction

Licen Xu is a prominent inventor based in Fremont, CA, known for her significant contributions to the field of cancer treatment. With a focus on signal transduction, her work has the potential to impact the diagnosis and treatment of various cancers, particularly breast and colon cancer.

Latest Patents

Licen Xu holds a patent for "Compositions and methods of diagnosis and treatment using casein kinase I." This invention is directed towards compositions and methods for affecting signal transduction through the casein kinase I (CKI) gene or gene product. More specifically, it targets the Wnt signal pathway, utilizing the CKI gene or gene product to diagnose and treat disorders mediated by this pathway, especially hyperproliferative disorders like breast and colon cancer. Licen Xu has 1 patent to her name.

Career Highlights

Licen Xu has made significant strides in her career, working with Chiron Corporation, where she has been able to apply her innovative ideas in a practical setting. Her research focuses on the modulation of the Wnt signal pathway, which is crucial for understanding and treating various cancers.

Collaborations

Licen Xu has collaborated with notable colleagues in her field, including Stephen David Harrison and Lewis T Williams. These collaborations have further enhanced her research and contributions to cancer treatment.

Conclusion

Licen Xu's work in the field of cancer treatment through the modulation of the Wnt signal pathway showcases her innovative spirit and dedication to improving healthcare. Her contributions are paving the way for advancements in the diagnosis and treatment of cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…